AQUC · Aquaron Acquisition Corp.
Price & Indicators
Up next
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Shell Companies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
AQUC
this stock
Aquaron Acquisition Corp.
|
$20.95M | — | — | — | 0.0% |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | — | — | — | — |
|
CCXI
Churchill Capital Corp XI
|
$744.99M | — | — | — | 6.0% |
|
DMII
Drugs Made In America Acquisition II Corp.
|
$646.55M | +2.5% | — | — | 0.2% |
|
EVAC
EQV Ventures Acquisition Corp. II
|
$601.43M | +2.6% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- % held
- 9.5%
- Net QoQ
- -511.4K sh
- Top holder
- Karpus Management, Inc.
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| AQUC | +4.3% | +4.9% | +13.2% | +14.2% | +0.1% |
| SPY | +1.0% | +4.1% | +7.2% | +1.0% | +6.5% |
| vs SPY | +3.3% | +0.9% | +6.0% | +13.1% | -6.4% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.